ScienceDex / Researcher record
Tuomas Tammela
- Memorial Sloan Kettering Cancer Center (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #5,516
- R01 Holder
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,494,898 | 4 | #3,649 |
| 2025 | $3,245,918 | 5 | #2,985 |
| 2026 | $3,245,922 | 5 | #5,516 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20244 records
- FY20255 records
- FY2026 · selected5 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11948169Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0003-3675-6961Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Internal Medicine
FY2026 award records by amount
NIH award records listing Tuomas Tammela as a PI. Multi-PI records show the full award amount for context.
- 5R01CA297077-02R01Co-investigatorMetabolic control of malignant fates in lung cancer$730.4Kaward amount
- 5R01CA293718-03R01Co-investigatorTargeting cell state transitions driving resistance to KRAS inhibitors in lung cancerNYU Grossman School of Medicine · Internal Medicine (NIH department code)$718.3Kaward amount
- 5R01CA290400-03R01Contact PIInvestigating hypoxia as a determinant of malignant fates in pancreas cancer$695.1Kaward amount
- 5R01CA270116-04R01Contact PITargeting plasticity in lung cancer$611.3Kaward amount
- 5R37CA244911-07R37Contact PITargeting stem-like cells and their niche in pancreatic cancer$490.8Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Tuomas Tammela as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMemorial Sloan Kettering Cancer Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3649
- 2024Entered Top 25% NationallyRanked #3649
- 2025$5M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Tuomas Tammela.